Food for thought: The role of nutrition in the microbiota-gut–brain axis  by Oriach, Clara Seira et al.
Clinical Nutrition Experimental 6 (2016) 25e38Contents lists available at ScienceDirect
Clinical Nutrition Experimental
journal homepage: ht tp: / /
www.cl in icalnutr i t ionexper imental .comFood for thought: The role of nutrition
in the microbiota-gutebrain axis
Clara Seira Oriach a, d, 1, Ruairi C. Robertson b, c, d, 1, Catherine Stanton c, d,
John F. Cryan d, e, Timothy G. Dinan a, d, *
a Department of Psychiatry and Neurobehavioural Science, University College Cork, Ireland
b School of Microbiology, University College Cork, Cork, Ireland
c Teagasc Moorepark Food Research Centre, Fermoy, Co. Cork, Ireland
d APC Microbiome Institute, University College Cork, Cork, Ireland
e Department of Anatomy and Neuroscience, University College Cork, Irelanda r t i c l e i n f o
Article history:
Received 12 October 2015
Received in revised form 4 January 2016
Accepted 4 January 2016
Available online 21 January 2016
Keywords:
Diet
Psychobiotics
Gut microbiota
Gutebrain axis
Psychiatric disorders* Corresponding author. Department of Psychiat
E-mail address: t.dinan@ucc.ie (T.G. Dinan).
1 Authors contributed equally to the completion
http://dx.doi.org/10.1016/j.yclnex.2016.01.003
2352-9393/©2016TheAuthors. PublishedbyElsevie
an open access article under the CC BY-NC-ND licenss u m m a r y
Recent research has provided strong evidence for the role of the
commensal gut microbiota in brain function and behaviour. Many
potential pathways are involved in this bidirectional communication
between the gut microbiota and the brain such as immune mecha-
nisms, the vagus nerve and microbial neurometabolite production.
Dysbiosis of gut microbial function has been associated with behav-
ioural and neurophysical deﬁcits, therefore research focused on
developing novel therapeutic strategies to treat psychiatric disorders
by targeting the gutmicrobiota is rapidly growing. Numerous factors
can inﬂuence the gut microbiota composition such as health status,
mode of birth delivery and genetics, but diet is considered among the
most crucial factors impacting on the human gut microbiota from
infancy to old age. Thus, dietary interventionsmay have the potential
to modulate psychiatric symptoms associated with gutebrain axis
dysfunction. Further clinical and in vivo studies are needed to better
understand the mechanisms underlying the link between nutrition,
gut microbiota and control of behaviour and mental health.
© 2016 The Authors. Published by Elsevier Ltd on behalf of
European Society for Clinical Nutrition and Metabolism. This is an
open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).ry, Cork University Hospital, Wilton, Cork, Ireland.
of the manuscript.
r Ltdonbehalfof EuropeanSociety forClinicalNutrition andMetabolism. This is
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1. Introduction
The microbial population residing in the small and large intestine represents the largest microbial
population of the human microbiota. Estimates suggest that bacterial cells within the gut microbiota
outnumber human eukaryotic cells by ten to one [1]. Moreover, the genes encoded by the gut micro-
biota, the gut microbiome, outnumber the human genome by one hundred to one [2]. This complex
ecosystem is formedmainly bybacteria, but also viruses, archae, protozoa and fungi. Due to the advances
in genomic technologies it has beenpossible to unravel around 75% of the adult gutmicrobiota bacterial
composition, which is predominantly composed of the Firmicutes and Bacteroidetes phyla [3].
Furthermore, the gutmicrobiota plays amajor role in host health by shaping the development of the
immune system, metabolizing dietary nutrients (such as fatty acids, glucose and bile acids) and drugs,
digesting complex indigestible polysaccharides and synthesizing vitamins and bioactive molecules [4].
Throughout different life stages, various changes occur in the microbial diversity of humans. Early
studies suggested that the foetus ﬁrst came in contact withmicrobes during birth. However, it has been
posited that as early as the prenatal period, an initial inoculum of microbes may be translocated via the
bloodstream and placenta from the mother to the foetus, thus contradicting the “sterile womb” hy-
pothesis [5].
After birth, the ﬁrst colonizers of the gut are facultative anaerobes such as Streptococcus, Enter-
obacteriaceae and Staphylococcus. These colonizers consume oxygen, creating an anaerobic environ-
ment leading to an increase of Clostridium, Bacteroides and Biﬁdobacteria, which are strict anaerobes.
During this early post-natal period, diet (breast milk/formula feeding) plays a key role in shaping the
gut microbiota composition [6]. This unstable infant gut microbiota with low diversity goes through a
number of compositional changes during the ﬁrst two years of life. From the second year of life onward,
the microbial composition undergoes an important shift toward the stable gut microbiota proﬁle of the
adult, which is composed mainly of Bacteroidetes and Firmicutes. During healthy adulthood the gut
microbiota remains relatively stable until ageing, when considerable changes occur [7].
The intestinal microbes are markedly affected by numerous factors such as host genetics, mode of
delivery, lifestyle (urbanization and global mobility), medical interventions (use of antibiotics, vacci-
nations and hygiene) and health status [8]. Furthermore, diet has repeatedly shown to be one of the
most important factors affecting gut microbiota establishment and composition throughout the life-
span [4]. Indeed, more than 50% of the variation of gut microbiota has been related to dietary changes
[9] and major changes in diet during adulthood can modify the microbiota in a matter of days [10].
C.S. Oriach et al. / Clinical Nutrition Experimental 6 (2016) 25e38 27Furthermore, an alteration of gut microbiota and metabolism, through dietary or other environ-
mental inﬂuences, can cause a state of dysbiosis, which is characterized by an overgrowth of potentially
pathogenic organisms (pathobionts) [11]. This change in the balance of symbionts/pathobionts can
induce reduced intestinal barrier function (leaky gut) and subsequent chronic inﬂammation. Such
dysbiosis may be associated to some metabolic and inﬂammatory disorders, visceral pain and even
alterations to central nervous system (CNS) functioning [12,13]. Hence the relationship between the
gut microbiota, chronic inﬂammation and the CNS suggest that microbial dysbiosis could alter brain
function and hence contribute to behavioural and cognitive abnormalities [14]. A wealth of preclinical
research is now showing potential for the treatment of dysbiosis, through dietarymeasures, to improve
cognitive and behavioural outcomes.
Given such evidence, there is a growing appreciation for the importance of the gut microbiota in
health and disease, including mental health. Bearing in mind that diet is one of the most crucial factors
in the development of the human gut microbiota from infancy to old age, this review focuses on the
role of the gutebrain axis in brain function and behaviour and the potential nutritional interventions to
target this axis as psychiatric disease therapies.
2. How does diet inﬂuence human microbiota?
The human gut harbours over ten thousand species of microorganisms [15], hence such taxonomic
diversity requires a wide array of nutrients and energy sources for normal microbial growth and
function. Narrowing of host dietary diversity and reduced intake of essential nutrients can therefore
reduce availability of substrates for speciﬁc microbial growth and contribute to intestinal dysbiosis.
Over recent decades, modern dietary patterns have undergone major compositional changes, with
increased intakes of redmeat, high fat foods, and reﬁned sugars. This ‘Westernization’ of diets together
with sedentary lifestyles results in modiﬁcations to the gut microbiota, which may partially contribute
to the higher incidences of chronic inﬂammatory disorders, such as cardiovascular disease, obesity,
depression, allergies, diabetes and autoimmune disorders [16]. It is therefore clear that in order to
improve the nutritional value of food and thus, human health, it is essential to understand the bio-
logical interactions between the diet and microbiota.
Many human studies have assessed dietary impact on the gut microbiota. However, as is the case
with many human studies, they are limited by the difﬁculties to control potential confounding vari-
ables such as habitual diets and lifestyle behaviours. Moreover, it is worth noting that, typically,
sequencing of the human gut microbiota is carried out on faecal samples, which may not accurately
reﬂect themicrobiota composition of the different intestinal segments. Despite these limitations, much
of this human data is useful to assess the role of varying dietary patterns on microbiota composition
and function.2.1. Rural vs western diet
Many studies comparing rural and western communities have revealed speciﬁc gut microbiota
adaptations to their respective environments. The adaptations to westernization have resulted in an
important loss of several bacterial species, and hence subsequent reduction in microbial diversity
and stability. Recent studies have clearly showed this reduction in microbiota diversity such as the
one comparing an Italian urban control group compared to a hunteregatherer community [17].
Moreover, recent investigations have reported the impact of diet on the microbial biodiversity
within different human populations [18]. African children, who consume a low-fat and high-ﬁbre
diet, presented less potentially pathogenic bacteria and greater degree of diversity and microbial
richness than European children consuming a high-fat diet (Western diet). African children had a
depletion in Firmicutes and a greater abundance of the phylum Bacteroidetes (Xylanibacter and
Prevotella), while European children showed a signiﬁcant increase of Firmicutes (Faecalibacterium
and Acetitomaculum) and Enterobacteriaceae (Shigella and Escherichia) [18]. Similar ﬁndings were
observed in terms of an increase of Prevotella genus in rural African populations compared to US
Americans [19].
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The Mediterranean diet is characterised by an abundance of fruits, vegetable, grains and mono-
unsaturated or n-3 polyunsaturated fats. Hence it is regarded as the gold-standard for optimum health.
A recent study showed the ability of a Mediterranean-inspired anti-inﬂammatory diet to reduce
inﬂammation in Crohn's disease. The results demonstrated a small reduction of the acute phase protein
C-reactive protein (CRP), an increase in Bacteroidetes and Clostridium clusters and a decrease in Pro-
teobacteria and Bacillaceae population [20]. Similarly De Filippis et al. recently observed that Italian
subjects with a high adherence to a Mediterranean diet had greater abundance of Prevotella and short
chain fatty acids. Conversely, those with low adherence had higher urinary trimethylamine oxide
(TMAO), which has associations with gut dysfunction, cardiovascular disease and colorectal cancer
[21].
2.3. Vegetarian/vegan diets
Vegetarian diets have also gained recognition as a healthy and therapeutic dietary pattern for a
number of chronic diseases, while vegan diets may confer protective beneﬁts beyond that of vegetarian
diets [22]. Vegan diets may have protective effects against metabolic and inﬂammatory diseases.
Moreover, they appear to lead to a unique gut microbiota proﬁle characterized by a reduction of
pathobionts [22]. Some studies have shown that vegetarian and vegan diets signiﬁcantly decrease
microbial counts of Bacteroides fragilis compared to an omnivore diet [23]. Another study comparing
vegetarian to omnivore diet observed a higher ratio (%) of BacteroidesePrevotella, Bacteroides the-
taiotaomicron, Clostridium clostridioforme and Faecalibacterium prausnitzii but a lower ratio (%) of the
Clostridium cluster XIVa in vegetarian diet [24].
2.4. High-ﬁbre diets
Numerous studies support the idea that diets rich in plant ﬁbres may promote the diversiﬁcation of
the microbiota by promoting hydrolytic bacteria and stimulating the production of short chain fatty
acids [18]. High-ﬁbre diets have been positively associated with Actinobacteria and Bacteroidetes
presence [25]. One study showed that three diets with different ﬁbre-rich whole grains (barley, brown
rice or combination of both) increased microbial diversity, the Firmicutes/Bacteroidetes ratio, and the
abundance of the genus Blautia in fecal samples [26]. Furthermore, the administration of whole grain
barley induced an increase in Biﬁdobacteriawhich is considered a positive indicator of prebiotic activity
[27]. A recent study found an elevation of Biﬁdobacteria and a reduction of Bacteroides spp. and Clos-
tridium histolitycum group in a cohort of overweight adults after administration of prebiotics (GOS)
[28]. Davis et al. showed as well that an administration of GOS increased abundance of Biﬁdobacter-
iaceae and decreased Bacteroidaceae family [29].
2.5. High-fat diets
Over the last few decades, the increase in the consumption of high-fat diets has been associated
with the obesity epidemic [30]. Many studies have shown that high-fat diets lead to a decrease in
Bacteroidetes and an increase in Firmicutes [31]. These effects may be associated with increased gut
permeability, a higher capacity for energy harvest and storage, and inﬂammation [31].
Several studies have focused on dietary supplementation as a possible way to attenuate the gut
microbiota dysbiosis and metabolic impairments produced by high-fat diets. For example, poly-
phenols, conjugated linoleic acid and short chain fatty acids supplementation during high-fat diet
consumption, have displayed an improvement of gut microbiota dysbiosis [32e34].
2.6. High-protein diets
The western diet has experienced a considerable increase in protein content in recent times. This
has led to much research examining variations in macronutrients intake in order to manage body
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intestine microbiota triggering the production of numerous amino acid-derived metabolites such as
phenols, indoles, amines, sulphide, ammonia and monocarboxylic acids [36].
Dietary protein intake in humans has been associated with the Bacteroides enterotype [25]. An
animal-based diet in humans showed an increase in the abundance of bile-tolerant microorganisms
(Alistipes, Bilophila and Bacteroides) and a decrease in the levels of Firmicutes that metabolize dietary
plant polysaccharides (Roseburia, Eubacterium rectale and Ruminococcus bromii) [10]. Interestingly,
Clarke et al. showed the importance of exercise in the relationship between the microbiota, host im-
munity and host metabolism, and the important role played by the diet. They compared male elite
professional rugby players to healthy male controls, ﬁnding a positive correlation between protein
consumption with microbial diversity [37].
3. Gut-microbiotaebrain communication
As previously discussed, diet signiﬁcantly modiﬁes host gut microbiota composition and function.
Simultaneously, however, gut microbiota determinewhat the host is capable of extracting from its diet,
from nutrients to bioactive signalling molecules such as neurometabolites, vitamins and short-chain
fatty acids (SCFA) [38]. Many of these molecules such as serotonin and gamma-aminobutyric acid
(GABA), have neuro-active functions due to their capacity to modulate neural signalling within the
enteric nervous system and consequently inﬂuence brain function and host behaviour [39].
This gutebrain axis, the bidirectional communication system between the gastrointestinal system
and the CNS, plays an important role in homeostasis between neural (both enteric and central nervous
systems), hormonal and immunological signalling [14]. Through this complex network the gut can
inﬂuence the brain via visceral messages, and conversely, the brain is able to inﬂuence gastrointestinal
functions (like motility, secretion and mucin production) and immune functions, such as the modu-
lation of cytokine production by cells of the mucosal immune system [40].
Both luminal nutrients and gut microbiota metabolites stimulate enteroendrocrine cells (EECs)
located throughout the gastrointestinal (GI) tract, which represents the largest endocrine organ in the
human body [41]. These EECs contain most of the nutrient receptors such as those for aminoacids,
peptones, SCFAs, long-chain fatty acids (LCFAs) and oleoylethanolamide (OEA) (Fig. 1). Molecular
sensing by these EEC's are crucial in the control of multiple functions during digestion, the initiation of
neural and hormonal responses or changes in mucosal ion transport which controls appetite, insulin
secretion andmotility [42]. Moreover, as the nervous and endocrine signalling between the gut and the
brain is essential for the modulation of many GI functions, the sensing receptors of the gut that control
the release of many hormones play a key role (Fig. 1). Several interacting factors such as diet and
microbiota composition modulate the activation of different sensory receptors in the gut, and conse-
quently stimulate up or down-regulation of hormonal releasewhich can induce a number of functional
GI changes. Interestingly, increasing evidence indicates that animals fed on a high-fat diet present
numerous changes in gastrointestinal function, particularly in the secretion and signalling of gastro-
intestinal hormones, which may predispose to an increase in energy intake, and consequently, to
weight gain and obesity [43].
In addition to its role as a sensory organ, the gut forms part of the enteric nervous system, which
makes up a comprehensive division of the autonomic nervous system, containing between 200 and
600 million neurons [42]. The vagus nerve (the major nerve of the parasympathetic division of the
autonomic nervous system) is crucially involved in bidirectional signalling between the gastrointes-
tinal and nervous systems (Fig. 2). A landmark study by Bravo et al. [44] found that probiotic modu-
lation of the gut microbiota induced behavioural and neurochemical changes in mice. However, this
was not apparent in mice that had undergone vagotomy suggesting a crucial role for the vagus nerve in
the gutebrain axis.
The human intestine also acts as an endocrine organ through direct and indirect production of
microbial metabolites and neurometabolites such as short chain fatty acids (SCFAs), vitamins and
neurotransmitters, which have also been shown to inﬂuence gutebrain interactions [8]. GABA and
serotonin are neurotransmitters that can inﬂuence host behaviour and are produced directly or indi-
rectly by certain commensal microbes [45,46]. SCFAs including butyrate, propionate and acetate can be
Fig. 1. Interactions between luminal nutrients and gut microbiota metabolites with the gut sensory receptors, and the key com-
munications between endocrine, neuronal and immune systems. Dietary composition determines the type of nutrients that reach
the luminal gastrointestinal tract. Different dietary patterns can alter the composition of the gut microbiota and consequently the
production of their metabolites, which can inﬂuence: epithelial permeability by acting on the cells from the immune system (1),
activity of enteroendocrine cells (2) or tight junction protein function (3). The gut luminal content is continuously monitored by the
intestine to optimize nutrient assimilation and protect against hazards which can affect its integrity. Therefore, the intestine is
conferred with a range of sensory receptors which interact with major effector systems such as the endocrine system, the nervous
system, the gut immune system, and the nonimmune defence systems of the gut. Hormone release triggered by the activation of
nutrient-speciﬁc receptors found on the enteroendrocrine cells, occurs along the entire gastrointestinal tract from the stomach to
the large intestine. There are several types of enteroendocrine cells such as L cells or I cells with sensory receptors that stimulate the
release of different types of hormones (4), which have a wide range of effects such as satiety through the hypothalamus, gastro-
intestinal motility and acid secretion. Abbreviations: Aas, aminoacids; Ach, acetylcholine; APCs, antigen-presenting cells; CCK,
cholecystokinin; DA, dopamine; GABA, gamma-aminobutyric acid; GIP, gastric inhibitory peptide; GLP, glucagon-like peptide; IPANs,
intrinsic primary afferent neuron; LCFAs, long-chain fatty acids; NE, norepinephrine; OEA, oleoylethanolamide; PYY, peptide YY;
SCFAs, short-chain fatty acids.
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polysaccharides [47]. Butyrate and propionate can modulate brain functioning, in particular appetite
regulation and energy homeostasis [48] through regulation of neuropeptide production.
The role of the gut microbiota in immune activation also has strong associations with neurological
functioning. The gut microbiota regulate intestinal epithelial barrier integrity and hence control the
translocation of viable bacteria or bacterial endotoxins into the bloodstream [49]. Increased intestinal
permeability can lead to increased lipopolysaccharide (LPS) in the bloodstream, which increases in-
ﬂammatory status. Diet and obesity signiﬁcantly alter gut microbiota composition and hence have
been shown to affect inﬂammatory status. Cani et al. showed that prebiotic supplementation damp-
ened inﬂammatory status and improved gut barrier function in genetically obese mice [50]. Many
supporting studies have demonstrated the potential for high fat and other obesogenic diets to promote
inﬂammation and microbiota-targeted interventions, such as prebiotics and probiotics to reverse in-
ﬂammatory status [51]. Chronic inﬂammation has been linked to a number of neurological disorders
including depression and dementia [52] and hence microbiota-associated chronic inﬂammation may
inﬂuence risk of such disorders.
Due to the fact that many of these gastrointestinal pathways signiﬁcantly inﬂuence neurological
function, there is potential for dietary interventions that increase bacterial metabolism and promote
growth of beneﬁcial bacteria, to positively modulate the gutebrain axis and improve symptoms of
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anxiety-related behaviour [8], research has recently focused on the health beneﬁts of probiotic
administration on psychiatric illnesses [53].
4. Microbiota-targeted dietary interventions and behavioural outcomes
The gut microbiota have been implicated in a number of clinical neuropsychiatric disorders [14].
Also, the role of nutrition in the aetiology and treatment of psychiatric disorders has come to light in
recent times [54]. The development of next generation sequencing technologies has also allowed for
increased understanding of human gut microbial composition in healthy and disease states and how
environmental factors such as diet inﬂuence this composition.
4.1. Probiotic interventions
A number of studies have reported certain probiotic strains, primarily Lactobacillus and Biﬁdobac-
teria, to enhance brain function in both rodents and humans. Hence there is potential for ‘psycho-
biotics’ (live organisms that, when ingested, confer a beneﬁt to host psychiatric health) tomodulate theFig. 2. Impact of diet on the gut microbiota and routes of communication involved in the gutebrain axis. Diet is one of the most
crucial factors in the development of the human gut microbiota. Different dietary patterns can change the gut microbiota
composition by keeping a balanced diversity of the gut microbiota (symbiosis) or causing a state of dysbiosis which is characterized
by an overgrowth of potentially pathological organisms (pathobionts). A state of dysbiosis leads to an increased inﬂammation and
leaky gut. Many mechanisms have shown to be involved in this bidirectional pathway between the gut microbiota and brain
including vagus nerve signalling, immune activation, tryptophan metabolism and production of microbial metabolites and neuro-
metabolites. Many of these bacterial metabolites signiﬁcantly impact neurological function, therefore there is potential for dietary
interventions that increase bacterial metabolism and promote growth of beneﬁcial bacteria, to beneﬁcially modulate the gutebrain
axis and modulate CNS function. Abbreviations: GABA, gamma-aminobutyric acid; DA, dopamine; NE, norepinephrine; Ach,
acetylcholine; SCFAs, short-chain fatty acids; 5-HT,serotonine; CNS, central nervous system.
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comprehensive list of human and preclinical studies investigating the role of probiotics in behav-
iours associated with psychiatric illness. Despite the promising evidence in animals, these results have
yet to be fully translated into humans. However with larger randomised controlled trials, there is
potential for psychobiotics to be effective psychiatric therapeutics.
4.2. Dietary interventions
Many studies have shown a clear association between the gut microbiota and behavioural alter-
ations, and given that gut microbiota is affected by diet, the composition of the diet may be a crucial
factor contributing to these behavioural changes, as summarized in Table 2.
Large macronutrient alterations as reﬂected in western style diets have been shown to induce
microbial dysbiosis, which has been linked to impaired cognition. Magnusson et al. examinedTable 1
Probiotic interventions and behavioural outcomes.
Intervention Species Health status Microbiota changes Behavioural/neurochemical outcomes References
Lactobacillus casei Humans Healthy d [ mood (self reported)
Y memory
[66]
Biﬁdobacteria
longum
Mice Healthy anxious
strain (BALB/c)
d [ memory and cognitive performance
(novel object recognition, barnes maze,
fear conditioning)
[67]
VSL#3 Rats Aged [ Bacteroidetes Y deﬁcit in age-related LTP
Y microglial activation
[ BDNF and synapsin
[68]
Lactobacillus
helveticus
Mice Healthy or fed
western-diet
Normalized the
increase in
Proteobacteria
following “western
diet” feeding
[ memory (Barnes maze)
Y anxiety-like behaviour (Barnes maze)
[59]
Bacteroides
fragilis
Mice MIA treated Restored relative
abundance of
lachnospiraceae
following MIA
treatment
Y anxiety-like behaviour (Open ﬁeld)
[ communication (ultrasonic
vocalization)
Y stereotyped behaviour (marble
burying)
[69]
Lactobacillus casei Humans Chronic fatigue
syndrome
[ Biﬁdobacteria
[ Lactobacillus
Y anxiety [70]
Lactobacillus
helveticus and
Biﬁdobacterium
longum
Rats Healthy d Y anxiety (conditioned defensive
burying)
[71]
Humans Healthy d Y anxiety
Biﬁdobacteria
infantis
Rats Healthy d Y proinﬂammatory immune response
[ tryptophan
[72]
Lactobacillus
rhamnosus and
Biﬁdobacterium
animalis
Humans Schizophrenic Microbiota data not
reported however
probiotic group
signiﬁcantly less
likely to experience
severe bowel
difﬁculty
No observed differences [73]
Biﬁdobacterium
infantis
Rats Healthy
normosensitive
(SpragueeDawley)
and healthy
hypersensitive
(WistareKyoto)
d Y visceral pain (colorectal distension) [74]
Lactobacillus
rhamnosus
Mice Healthy anxious
strain (BALB/C)
d Y corticosterone, anxiety behaviour,
depressive behaviour. Altered GABA
receptor expression
[44]
Abbreviations: MIA, maternal immune activation; LTP, long-term potentiation; GABA, gamma-aminobutyric acid.
Table 2
Microbiota-targeted dietary interventions and behavioural outcomes.
Diet Species Intervention
length
Microbiota changes Behavioural
outcomes
Biochemical outcomes
(possible mechanisms)
References
High-fat diet Mice 13 weeks [ Firmicutes
(mainly
Ruminococcaceae
and
Lachnospiraceae)
Y Bacteroidetes
(S24-7)
Y Burrowing
(Burrowing Test)
Y Memory (Morris
water maze test)
No difference between diet
groups was observed for
sucrose preferences, LPS,
cholesterol, HbA1c, BDNF
and the cytokines IL-1a,
IL-1b, IL-6, IL-10, IL-
12(p70), IL-17 and TNF-a.
Low-grade levels of the
systemic inﬂammatory
mediators IL-6, IL-12p70
and IL-17A correlated to
memory, anxiety,
anhedonia and species-
typical behaviour
[56]
High-fat diet Mice 2e5 weeks [ Clostridiales and
Erysipelotrichales
Y Bacteroides
No signiﬁcant
differences from
the control mice,
except for
remaining focused
on the old platform
position during the
reversal probe trial
d [55]
High-sucrose diet Mice 2e5 weeks [ Clostridiales,
Lactobacillus
(Enterococcus,
Lactococcus and
Lactobacillus) and
Lactococcus
Y Bacteroides
Y Learning (Morris
water maze test)
Cognitive deﬁcits
(in spatial short-
term memory)
Impairments in
early development
of a spatial bias for
long-term memory,
short-term
memory and
reversal training,
compared to mice
on normal diet
d [55]
MgD diet Mice 6 weeks Principal
Component
Analysis plots
illustrating
differences in GM
composition. The
GM proﬁle of MgD
mice differed
signiﬁcantly from
mice fed a standard
control diet
[ FST e Increased
immobility
(depressive-like
phenotype)
Strong tendency towards
decreased mRNA IL-6 levels
in the MgD mice. The GM of
MgD mice correlated
signiﬁcantly to
hippocampal IL-6 levels
[61]
MgD diet Mice 6 weeks Y Bacterial
diversity of the gut
Principal
component
analysis plots
illustrating
differences in GM
composition
between mice fed a
control diet or an
MgD diet
Altered anxiety-like
behaviour
(Y Latency to enter
the light
compartment in the
Light Dark Box test)
d [62]
(continued on next page)
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Table 2 (continued )
Diet Species Intervention
length
Microbiota changes Behavioural
outcomes
Biochemical outcomes
(possible mechanisms)
References
Meat-containing
diets
Mice 3 months [ Bacterial
diversity
[Working and
reference
(temporary and
long-term)
memory.
Y Anxiety-like
behaviour
d [57]
Western-style
diet high in fat
Mice 21 days [ Firmicutes/
Bacteroidetes ratio
[ Abundance of
Proteobacteria and
Spirochaetes
Altered anxiety-like
behaviour
Y total levels of SCFAs in
cecal contents
Y levels of acetic, propionic
and butyric acids
[ levels of caproic acid
[59]
High-fat diet (fecal
transplantation
from donors on
high-fat diet)
Mice 10 weeks Sequencing-based
phylogenetic
analysis conﬁrmed
the presence of
distinct core
microbiota
between groups,
with alterations in
a- and b-diversity,
modulation in
taxonomic
distribution, and
statistically
signiﬁcant
alterations to
metabolically
active taxa
Disrupted
exploratory,
cognitive, and
stereotypical
behaviour
Disrupted markers of
intestinal barrier function
[ circulating endotoxin
[ lymphocyte expression of
ionized calcium-binding
adapter molecule 1
[ toll-like receptor 2
[ toll-like receptor 4
[58]
High-fat diet Mice 8 weeks [ Firmicutes
Y Bacteroidetes and
Tenericutes
Robust anxiety
phenotype
d [60]
Diet supplemented
with prebiotics
(trans-GOS)
Human 8 weeks Enhanced
Biﬁdobacteria
Improved anxiety
(HAD scale)
d [65]
Abbreviations: HAD, Hospital Anxiety and Depression scale; SCFAs, short-chain fatty acids; GM, gut microbiota; LPS, Lipo-
polysaccharide; HbA1c, hemoglobin A1c; BDNF, brain-derived neurotrophic factor; trans-GOS, trans-galactooligosaccharides;
MgD diet, diet deﬁcient in Magnesium.
C.S. Oriach et al. / Clinical Nutrition Experimental 6 (2016) 25e3834microbiota compositional changes following high fat, high sucrose or standard chowdiets and assessed
associations with cognitive capabilities in mice [55]. Lactobacillus was signiﬁcantly increased in the
high sucrose group whereas Erysipelotrichaleswas signiﬁcantly increased in the high fat group. High fat
and high sucrose both had increased Coriobacteriales and reduced Bacteroides. Both high-energy
treatments induced impaired cognition in the Morris water-maze and step-down latency tasks. In
addition these behavioural changes displayed signiﬁcant correlations with the alterations in Lacto-
bacillus, Erysipelotrichales, Coriobacteriales and Bacteroides. These results suggest that the cognitive
changes induced by the western-style diets are mediated through alterations to the gut microbiota.
Jørgensen et al. performed a similar study with the same treatment groups and found similar corre-
lations between microbiota alteration and memory which was also associated with inﬂammatory
status [56].
Li et al. also reported diet-induced changes tomicrobial diversity to improve cognition and working
memory in mice. In this study, a meat-containing diet led to greater gut microbiota diversity than
found in the control diet group. Moreover, the meat-containing diet group had improved working and
reference memory on the hole-board open ﬁeld test and less anxiety-like behaviour, assessed during
the novel encounter in the hole-board open ﬁeld [57].
Mental decline is increased by obesity, which may be in part regulated by gut microbiota dysbiosis.
A recent study showed that an obese-type microbiota, induced by high-fat feeding, induced cognitive
C.S. Oriach et al. / Clinical Nutrition Experimental 6 (2016) 25e38 35disruptions when transplanted into healthy rodents [58]. The high-fat diet microbiota led to a sig-
niﬁcant increase of anxiety-like behaviour in the elevated plus maze, open ﬁeld, and marble burying
test. Moreover, this transfer of the high-fat diet microbiota decreased the cued fear memory in com-
parison to mice that received microbiota from chow-fed mice. Furthermore, inﬂammatory markers in
the medial prefrontal cortex and intestinal permeability were increased in the mice who received the
high-fat diet microbiota, suggesting that immune signalling pathways may be key mediators of
microbiotaebrain communication. These interesting results revealed that even in the absence of
obesity, an obese-type microbiota proﬁle could induce behaviour deﬁcits similar to those seen in
obesity and hence suggesting the potential for microbiota-based dietary interventions to treat obese-
associated psychiatric disorders.
In addition, Ohland et al. reported a western-style diet to induce anxiety-like behaviour in mice, as
assessed in the Barnes maze [59]. Moreover, western-style diet feeding increased the Firmicutes/Bac-
teroidetes ratio, and the abundance of Proteobacteria and Spirochaetes as well as reducing total SCFA
contents. This increased anxiety-like behaviour was not apparent in mice who had been fed awestern-
style diet supplemented with the probiotic Lactobacillus helveticus.
Another study found that mice on a high-fat diet presented major shifts in the gut microbiota
(increase of Firmicutes and decrease of Bacteroidetes and Tenericutes) and a robust anxiety phenotype
[60].
A diet deﬁcient in Mg, increased depressive-like behaviour and altered the gut microbiota, which
suggested that magnesium deﬁciency could be amediator of the behavioural effects through an altered
gutmicrobiota [61]. Interestingly, a signiﬁcant correlationwas found between the gutmicrobiota of the
diet deﬁcient in Mg and a decrease in hippocampal IL-6 levels, suggesting that this immune-
modulation could be the mechanism by which diet induced changes in the gut microbiota composi-
tion alter behaviour [61]. A similar study found that a diet deﬁcient in Mg decreased bacterial diversity
and altered anxiety-like behaviour [62].
Certain prebiotics have the potential to inﬂuence central nervous system functioning through
stimulation of speciﬁc microbial growth and production of SCFAs. Tarr et al. reported that a social
disruption stressor signiﬁcantly altered gut microbiota composition inmice, which resulted in anxiety-
like behaviour and a reduction in the growth of neurons in the denate gyrus region of the hippocampus
[63]. Interestingly, supplementation of the human milk oligosaccharides 30 Sialyllactose or 60 Sia-
lyllactose, which have anti-inﬂammatory properties and stimulate biﬁdobacterial growth, prevented
the stressor-induced alterations to the gut microbiota, in addition to preventing the behavioural, mi-
crobial and neurophysical defects [63].
A number of small clinical controlled trials have assessed the efﬁcacy of certain prebiotics on
psychological outcomes with promising results. Schmidt et al. demonstrated that 3-week supple-
mentation with a GOS prebiotic, which has been shown to stimulate biﬁdobacterial growth, in healthy
volunteers signiﬁcantly reduced waking cortisol response, a stress hormone strongly linked to anxiety
and depression [64]. Moreover, a Bimuno®-galactooligosaccharides (B-GOS) cohort demonstrated
altered behavioural outcomes through a decrease in attentional vigilance to negative versus positive
information in a dot-probe task compared to placebo. It is interesting to note, however, that fructoo-
ligosaccharide (FOS) supplementation had no effect. These results suggest that shaping of microbiota
composition through prebiotic intake could inﬂuence behavioural outcomes [64]. In humans, prebiotic
supplementation with trans-galactooligosaccharides (trans-GOS) not only enhanced biﬁdobacterial
growth and improved bloating symptoms, but in addition signiﬁcantly reduced anxiety scores in IBS
sufferers [65].
5. Conclusions and future implications
It is evident that there are a number of major metabolic, endocrine and neural pathways connecting
the gut and the brain. Indeed, the trillions of microbes and microbial by-products within the gut
contribute to the plasticity of these pathways. Despite the rapid growth of this area of research, it is still
in its infancy. Relatively little is known about the extent to which bacterial metabolites can inﬂuence
brain function, something which could be addressed with further advances in metabolomic technol-
ogies. In addition, the complexity of the pathways involved in the gutebrain axis contributes to the
C.S. Oriach et al. / Clinical Nutrition Experimental 6 (2016) 25e3836difﬁculty of identifying true mechanisms of action. Moreover, the role of individual nutrients to affect
signalling within these pathways requires further examination.
Sequencing technologies have grown extensively in recent times allowing deeper insight into gut
microbial composition and associations between altered microbiota and psychiatric illnesses. Further
research in this ﬁeld should address mechanistic evidence for gut microbiota to alter brain and
behaviour. The majority of the data available, is preclinical and few of these promising studies have
been translated into humans, which warrants the need for more clinical trials in the area. There are
very little data reporting clinical interventions targeting the microbiota in psychiatric illness.
Indeed, diet has a signiﬁcant impact on the microbiota and hence dietary interventions can
beneﬁcially modulate microbial diversity and function. Caution must be taken on assigning the term
‘probiotic’ to a speciﬁc strain of bacteria until its health effects can be replicated in both humans and
animals. Indeed, commercial availability of true ‘psychobiotics’ (a live bacteria that may beneﬁt mental
health) will only become apparent after rigorous human trials. Prebiotics and other larger dietary
interventions, including dietary fats and polyphenols also pose potential to alter the gutebrain axis and
hence neuropsychiatric disorders, and may be feasible as long-term interventions for mental health.
In conclusion, diet-induced gut microbiota modiﬁcations may be associated with brain dysfunction,
behavioural and metabolic deﬁciencies. The emerging evidence of a microbiota-gutebrain axis dys-
regulation in certain neuropsychiatric disorders warrants further clinical and in vivo studies to
investigate gut microbiota-targeted interventions as novel therapeutic strategies. Indeed, dietary in-
terventions to treat dysfunction of the gutebrain axis may pose potential as therapeutic strategies for
psychiatric disorders.
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